Asundexian for Secondary Stroke Prevention
Original Article
M. Sharma, Q. Dong, T. Hirano, S.E. Kasner, J.L. Saver, J. Masjuan, A.M. Demchuk, C. Cordonnier, D. Bereczki, G. Tsivgoulis, R. Veltkamp, I. Staikov, H.-J. Bae, B.C. Campbell, A. Zini, I.-H. Lee, M. Kovar, R. Mikulik, R. Lemmens, J.M. Ferro, T. Robinson, H. Christensen, S. Ozturk, R.R. Leker, P. Turcani, A. Slowik, P. Amaya, F.K. Hoo, G.M.D. Marchis, M. Knoflach, P. Sylaja, J. Putaala, J.M. Coutinho, H.B.v.d. Worp, E. Miglane, V. Matijošaitis, A.G. Lindgren, G.S. Silva, E.C. Sandset, S.T. Turuspekova, P. Amarenco, K.N. Sheth, E.E. Smith, J.W. Eikelboom, R.A. Joundi, K. Schulze, L. Xu, L. Heenan, P. Colorado, L. Keller, E. Muehlhofer, C. Neumann, H. Mundl, and A. Shoamanesh
N Engl J Med 2026;394:1467-1479
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation

Facebook
X
LinkedIn
Forward